Ayala Pharmaceuticals Inc
(ADXS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 04-2007 | 01-2007 | 07-2006 | 04-2006 | |
| Sales | 8 | 146 | 0 | 67 |
| Gross Profit | 8 | 146 | N/A | 67 |
| Operating Expenses | 1,533 | 1,339 | 689 | 1,055 |
| Operating Income | -1,525 | -1,193 | -689 | -987 |
| Interest Expense | 212 | 153 | 151 | 113 |
| Other Income | -1,398 | 1,309 | 157 | -207 |
| Pre-tax Income | -3,136 | -37 | -683 | -1,307 |
| Net Income Continuous | -3,136 | -37 | -683 | -1,307 |
| Net Income | $-3,136 | $-37 | $-683 | $-1,307 |
| EPS Basic Total Ops | -0.07 | 0.00 | -0.02 | -0.03 |
| EPS Basic Continuous Ops | -0.07 | 0.00 | -0.02 | -0.03 |
| EPS Diluted Total Ops | -0.07 | 0.00 | -0.02 | -0.03 |
| EPS Diluted Continuous Ops | -0.07 | 0.00 | -0.02 | -0.03 |
| EBITDA(a) | $-1,451 | $-1,144 | $-651 | $-987 |